The global Medical Affairs Outsourcing Market Size is projected to reach US Dollar 2.8 Billion by 2027 and is projected to expand at a CAGR of ~10.75%% over the forecast period of 2020 to 2027.
Medical affairs play a fundamental character in overcoming blockades to access healthcare professionals (HCPs). Furthermore, compliance necessities mean medical affairs is accountable for offering HCPs with neutral, concurrent and translucent medical info. Eventually, in such progressively challenging setting, the onus is on medical affairs to gather high level data and interpret this info into value insights and programs that cater to the requirements of all participants such as HCPs, patients and government bodies among others.
Regardless of the noteworthy expansion and role which medical affairs department plays in the enactment and implementation of a corporation’s KOL development, clinical development, scientific publications, and medical education accomplishments, a topmost issue relic sis inadequate resources such as headcount and budget. Analogous to subcontracting models and arrangements inside the contract research and sales arenas, medical affairs outsourcing services afford businesses with scalable and flexible solutions allowing them to exploit resource component and strategic management and specialty degreed, healthcare personnel resources owning both therapeutic and discipline-specific proficiency. A foremost assistance cited by several medical affairs business executives is the aptitude to have these teams employed and educated very swiftly with the option to adapt the headcount throughout crucial initiatives and milestones grounded on business varying dynamics and marketplace.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1113
Growth Factors
Global medical affairs outsourcing market is propelled by escalating research and developments undertakings along with growing spending in the healthcare sector across the globe. Further rising emphasis on CROs and CMOs is supporting the market growth across different economies in the world. Geographically, Asia Pacific is expected projected show significant growth in the global market on account of fast turnaround period and stress-free obtainability of the trained and skilled professionals at low cost. Furthermore, augmented clinical trials across the world are also triggering the growth of global medical affairs outsourcing market. As per statistics offered by Word Health organization, the yearly number of registered clinical trials augmented from 3,344 in year 2004 to around 54,894 in the year 2018. As medical affair is significant support action for a successful clinical trial, its cumulative number is predicted to flourish growth of medical affairs outsourcing market during the years to come.
Report Highlights
- In 2019, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of the total market
- Cumulative R&D activities and expansion of novel products to lift the growth of medical regulatory affairs outsourcing market across the world
- Pharmaceutical industry segment conquered the global market by accounting prominent share more than 50% of the total revenue generated by market in 2019.
- The Medical Science Liaisons (MSLs) services segment projected to record firmest CAGR during assessment period.
Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1113
Regional Snapshots
North America occupied for the prominent revenue chunk of the total gathered by global medical affairs outsourcing market in 2019 across various segments. This region is foreseen to sustain this stronghold during next few years on account of existence of leading global life sciences and pharmaceutical organizations, rigorous regulators such as FDA and obtainability of skilled workforce pool across the region.
Asia Pacific is projected to record the utmost compounded annual growth throughout the estimate period due to contributing factors such as accessibility of low-cost labor and intensifying cases of regulatory filings. Expansion of pharmaceutical and leading life science firms in this region is further estimated to bolster demand for medical affair outsourcing in Asia Pacific. Asia Pacific is the firmest growing pharmaceutical sector across the world, offering noteworthy prospects for drug marketing and development. Accordingly, pharmaceutical regulations in APAC are attaining attention amongst pharmaceutical businesses worldwide.
Key Players & Strategies
Pharmaceutical and medical devices establishments are subcontracting medical affairs services to the CROs or contract research organizations to restrict the accountability exposure by functioning with a skilled outsource company. Further it helps them to decrease operational costs, curtail regulatory compliance hazard, and avert process delays. Some of the major participants contending in the market arena are IQVIA Holdings Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications, Syneos Health Inc., ICON plc, ZEINCRO Group, Pharmaceutical Product Development, LLC, Wuxi Clinical Development, Inc., Indegene Inc and SGS SA.
Few contemporary strategies implemented by market players are as follows:
In May 2017, Rich Pharma, Inc collaborated with IND 2 Results, LLC as a CRO to deliver medical writing, protocol development, and regulatory consulting services for its clinical trials on treatment of Acute Myelocytic Leukemia and Hodgkin's Lymphoma.
Charles River Laboratories International, Inc. acquired a non-clinical Contract Research Organization named CitoxlabIn April 2019. This firm provides the medical device testing, regulated safety assessment services, and other services.
Market Segmentation
By Services
- Medical Monitoring
- Medical Writing & Publishing
- Medical Information
- Medical Science Liaisons
- Others
By Industry
- Medical Devices
- Pharmaceutical
- Biopharmaceutical
By Regional Outlook
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Affairs Outsourcing Market, By Services
7.1. Medical Affairs Outsourcing Market, by Services Type, 2020-2027
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Medical Affairs Outsourcing Market, By Industry
8.1. Medical Affairs Outsourcing Market, by Industry, 2020-2027
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2016-2027)
9.1.2. Market Revenue and Forecast, by Industry (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Industry (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Industry (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2016-2027)
9.2.2. Market Revenue and Forecast, by Industry (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Industry (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Industry (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Industry (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Industry (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2016-2027)
9.3.2. Market Revenue and Forecast, by Industry (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Industry (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Industry (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Industry (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Industry (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2016-2027)
9.4.2. Market Revenue and Forecast, by Industry (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Industry (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Industry (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Industry (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Industry (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2016-2027)
9.5.2. Market Revenue and Forecast, by Industry (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Industry (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Industry (2016-2027)
Chapter 10. Company Profiles
10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1113
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 774 402 6168
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
0 Comments